Baseline clinical, angiographic and procedural characteristics for 539 patients with ST elevation myocardial infarction with diabetes mellitus
| Baseline characteristics | SVD N=264 (49%) | MVD (without CTO) N=162 (30%) | CTO N=113 (21%) | p Value |
| Male | 160 (61) | 104 (64) | 77 (68) | 0.36 |
| Age >60 years | 153 (58) | 121 (75) | 82 (73) | <0.01 |
| Hypertension | 137 (52) | 83 (51) | 53 (47) | 0.66 |
| Insulin-dependent diabetes mellitus* | 74 (28) | 49 (30) | 42 (37) | 0.21 |
| Smoker | 90 (34) | 47 (29) | 37 (33) | 0.55 |
| Hypercholesterolaemia | 82 (31) | 54 (33) | 43 (38) | 0.42 |
| Family history of cardiovascular disease | 98 (37) | 56 (35) | 25 (22) | 0.02 |
| Previous myocardial infarction | 32 (12) | 36 (22) | 59 (52) | <0.01 |
| Shock | 15 (5.7) | 16 (9.9) | 25 (22) | <0.01 |
| Left ventricular ejection fraction <40%† | 23 (22) | 17 (28) | 11 (31) | 0.44 |
| Angiographic characteristics | ||||
| LAD-related myocardial infarction | 128 (49) | 64 (40) | 45 (40) | 0.12 |
| Post-procedural TIMI flow grade 3 | 231 (88) | 144 (89) | 91 (81) | 0.11 |
| Procedural characteristics | ||||
| Thrombosuction performed | 86 (33) | 30 (19) | 20 (18) | <0.01 |
| Intra-aortic balloon pump | 13 (5) | 17 (11) | 30 (27) | <0.01 |
| Stent placement | 196 (74) | 106 (65) | 71 (63) | 0.04 |
| Glycoprotein IIb/IIIa inhibitor used | 70 (27) | 39 (24) | 31 (27) | 0.79 |
Data shown as N (%).
↵* Compared with non-insulin dependent diabetes mellitus.
↵† Left ventricular ejection fraction data were available for 202/539 patients.
CTO, chronic total occlusion; LAD, left anterior descending coronary artery; MVD, multivessel disease; SVD, single vessel disease; TIMI, thrombolysis in myocardial infarction.